Edward C. Ward

Array ( [id] => 2805619 [patent_doc_number] => 05145965 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1992-09-08 [patent_title] => '2,6-methanopyrrolo-3-benzazocines' [patent_app_type] => 1 [patent_app_number] => 7/666394 [patent_app_country] => US [patent_app_date] => 1991-03-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15572 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 98 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/145/05145965.pdf [firstpage_image] =>[orig_patent_app_number] => 666394 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2932060 [patent_doc_number] => 05219879 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1993-06-15 [patent_title] => 'Heterocyclic steroid compounds' [patent_app_type] => 1 [patent_app_number] => 7/664988 [patent_app_country] => US [patent_app_date] => 1991-03-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 62792 [patent_no_of_claims] => 58 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 381 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/219/05219879.pdf [firstpage_image] =>[orig_patent_app_number] => 664988 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2856880 [patent_doc_number] => 05166194 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1992-11-24 [patent_title] => 'Transdermally applicable pharmaceutical preparations having a pharmaceutically usable glycoside content' [patent_app_type] => 1 [patent_app_number] => 7/652380 [patent_app_country] => US [patent_app_date] => 1991-02-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1372 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 33 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/166/05166194.pdf [firstpage_image] =>[orig_patent_app_number] => 652380 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2785750 [patent_doc_number] => 05155107 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1992-10-13 [patent_title] => '17.beta.-substituted-4-aza-5.alpha.-androstan-3-one derivatives and process for their preparation' [patent_app_type] => 1 [patent_app_number] => 7/650970 [patent_app_country] => US [patent_app_date] => 1991-02-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15660 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 27 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/155/05155107.pdf [firstpage_image] =>[orig_patent_app_number] => 650970 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2680657 [patent_doc_number] => 05066650 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1991-11-19 [patent_title] => 'Method for suppressing the endocrine system' [patent_app_type] => 1 [patent_app_number] => 7/638623 [patent_app_country] => US [patent_app_date] => 1991-01-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 4536 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 42 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/066/05066650.pdf [firstpage_image] =>[orig_patent_app_number] => 638623 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2920196 [patent_doc_number] => 05234945 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1993-08-10 [patent_title] => 'Method of producing body weight and food intake using a dopamine D2 receptor agonist' [patent_app_type] => 1 [patent_app_number] => 7/641221 [patent_app_country] => US [patent_app_date] => 1991-01-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 5348 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 174 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/234/05234945.pdf [firstpage_image] =>[orig_patent_app_number] => 641221 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2801315 [patent_doc_number] => 05147650 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1992-09-15 [patent_title] => 'Compositions and methods for achieving improved physiological response to exercise' [patent_app_type] => 1 [patent_app_number] => 7/636329 [patent_app_country] => US [patent_app_date] => 1990-12-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 6180 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 45 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/147/05147650.pdf [firstpage_image] =>[orig_patent_app_number] => 636329 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2931761 [patent_doc_number] => 05219862 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1993-06-15 [patent_title] => '8 beta-substituted ergolines, process for their production and their use' [patent_app_type] => 1 [patent_app_number] => 7/623933 [patent_app_country] => US [patent_app_date] => 1990-12-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7038 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 29 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/219/05219862.pdf [firstpage_image] =>[orig_patent_app_number] => 623933 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2878360 [patent_doc_number] => 05159080 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1992-10-27 [patent_title] => 'Indole compounds, a process for their preparation, and pharmaceutical compositions containing them' [patent_app_type] => 1 [patent_app_number] => 7/629188 [patent_app_country] => US [patent_app_date] => 1990-12-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12969 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 10 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/159/05159080.pdf [firstpage_image] =>[orig_patent_app_number] => 629188 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2824111 [patent_doc_number] => 05169852 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1992-12-08 [patent_title] => 'Method of suppressing appetite by administration of tetrahydro-beta-carboline derivatives' [patent_app_type] => 1 [patent_app_number] => 7/628692 [patent_app_country] => US [patent_app_date] => 1990-12-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 15 [patent_no_of_words] => 8739 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 69 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/169/05169852.pdf [firstpage_image] =>[orig_patent_app_number] => 628692 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2974998 [patent_doc_number] => 05194602 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1993-03-16 [patent_title] => '9.alpha.-hydroxy-17-methylene steroids, process for their preparation and their use in the preparation of corticosteroids' [patent_app_type] => 1 [patent_app_number] => 7/474852 [patent_app_country] => US [patent_app_date] => 1990-12-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14072 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 188 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/194/05194602.pdf [firstpage_image] =>[orig_patent_app_number] => 474852 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2854627 [patent_doc_number] => 05126488 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1992-06-30 [patent_title] => '2.beta.,19-methyleneamino bridged steroids as aromatase inhibitors' [patent_app_type] => 1 [patent_app_number] => 7/621183 [patent_app_country] => US [patent_app_date] => 1990-11-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3473 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 20 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/126/05126488.pdf [firstpage_image] =>[orig_patent_app_number] => 621183 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2857018 [patent_doc_number] => 05166201 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1992-11-24 [patent_title] => '2.beta.,19-ethylene bridged steroids as aromatase inhibitors' [patent_app_type] => 1 [patent_app_number] => 7/621184 [patent_app_country] => US [patent_app_date] => 1990-11-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5068 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 81 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/166/05166201.pdf [firstpage_image] =>[orig_patent_app_number] => 621184 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2871087 [patent_doc_number] => 05162519 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1992-11-10 [patent_title] => 'Porphyrins and cancer treatment' [patent_app_type] => 1 [patent_app_number] => 7/617622 [patent_app_country] => US [patent_app_date] => 1990-11-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2837 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 54 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/162/05162519.pdf [firstpage_image] =>[orig_patent_app_number] => 617622 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2987345 [patent_doc_number] => 05212179 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1993-05-18 [patent_title] => 'Piperidine derivatives' [patent_app_type] => 1 [patent_app_number] => 7/603109 [patent_app_country] => US [patent_app_date] => 1990-10-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10142 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 189 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/212/05212179.pdf [firstpage_image] =>[orig_patent_app_number] => 603109 [rel_patent_id] =>[rel_patent_doc_number] =>)